Senior investor and operating executive focused on capital markets, corporate finance and value-oriented investing. Jeffrey M Bernstein is known for leading investment teams and directing portfolio strategy across public and private assets, with emphasis on fundamental research, risk management and portfolio construction. Active in deal sourcing, board engagement and restructuring assignments, the profile suits roles in asset management, private equity or strategic advisory.
Senior investor and operating executive focused on capital markets, corporate finance and value-oriented investing. Jeffrey M Bernstein is known for leading investment teams and directing portfolio strategy across public and private assets, with emphasis on fundamental research, risk management and portfolio construction. Active in deal sourcing, board engagement and restructuring assignments, the profile suits roles in asset management, private equity or strategic advisory.
Experienced value-oriented investor who emphasizes fundamental research, disciplined capital allocation and active portfolio construction across public and private markets. Prefers undervalued or dislocated opportunities in financials, industrials and corporate restructurings, blending event-driven and long-term value time horizons. Allocates capital with clear risk limits, concentrated high-conviction positions alongside hedged opportunistic sleeves. Operating edge derives from hands-on corporate finance experience, board engagement and restructuring playbooks used to unlock value. Decisions are data-driven, governance-focused and bias toward liquidity-aware, return-on-capital outcomes.
Experienced value-oriented investor who emphasizes fundamental research, disciplined capital allocation and active portfolio construction across public and private markets. Prefers undervalued or dislocated opportunities in financials, industrials and corporate restructurings, blending event-driven and long-term value time horizons. Allocates capital with clear risk limits, concentrated high-conviction positions alongside hedged opportunistic sleeves. Operating edge derives from hands-on corporate finance experience, board engagement and restructuring playbooks used to unlock value. Decisions are data-driven, governance-focused and bias toward liquidity-aware, return-on-capital outcomes.
| Trades 497 | Longs Won 313/497 62% | Profit Factor 2.28 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $946,699.02 |
| Average Win $238,893.82 | Best Trade (Aug 17) $14.77M | Sharpe Ratio -45.22 |
| Average Loss -$177,999.38 | Worst Trade (Jun 29) -$13.35M | Z-Score 4.89 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3w 2d | Expectancy $84,754.93 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 1.27% |
| Consecutive Losing Trades | 1,236 | 1,112 | 989 | 865 | 742 | 618 | 494 | 371 | 247 | 124 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 8855 88554DAD8 | 1.7M | $1.39M | $1.29M | - | -$101,320.86 | -7.27% | 0.0 |
AAPL Apple Inc. | 3,600 | $699,318.27 | $1.11M | - | $412,757.73 | 59.02% | -7.354% |
ACIU Acimmune SA | 10,000 | $39,900 | $21,900 | - | -$18,000 | -45.11% | -7.595% |
ADI Analog Devices, Inc. | 36,009 | $8.15M | $13.23M | - | $5.08M | 62.24% | +0.202% |
ALLT Allot Ltd. | 176,918 | $844,745.52 | $1.35M | - | $501,600.46 | 59.38% | +1.332% |
AMX América Móvil, S.A.B. de C.V. | 15,492 | $220,296 | $392,722.2 | - | $172,426.2 | 78.27% | +0.118% |
APYX Apyx Medical Corporation | 1.04M | $2.53M | $4.26M | - | $1.73M | 68.2% | -0.485% |
ARAY Accuray Incorporated | 658,915 | $1.47M | $177,907.06 | - | -$1.29M | -87.91% | -6.897% |
ASPI ASP Isotopes Inc. | 12,440 | $87,826.4 | $49,760 | - | -$38,066.4 | -43.34% | +0.503% |
AXP American Express Company | 2,645 | $854,839.14 | $889,381.25 | - | $34,542.11 | 4.04% | -0.376% |
BHST Bioharvest Sciences Inc. | 57,723 | $202,449.76 | $124,681.68 | - | -$77,768.08 | -38.41% | +0.935% |
BRT BRT Apartments Corp. | 157,558 | $2.62M | $2.35M | - | -$266,357.08 | -10.18% | -1.258% |
CCAP Crescent Capital BDC, Inc. | 29,560 | $460,003.14 | $323,090.8 | - | -$136,912.34 | -29.76% | +0.737% |
CEVA Ceva Inc. | 138,957 | $3.2M | $4.54M | - | $1.34M | 41.84% | -0.73% |
CGNT Cognyte Software Ltd. | 165,497 | $1.24M | $1.48M | - | $240,547.42 | 19.41% | +1.822% |
CTVA Corteva Inc. | 14,725 | $932,583.18 | $1.16M | - | $226,421.57 | 24.28% | -11.898% |
DDD 3D Systems Corporation | 2.79M | $9.57M | $7.36M | - | -$2.21M | -23.05% | -2.222% |
DMRC Digimarc Corporation | 798,422 | $7.6M | $5.24M | - | -$2.36M | -31.09% | +0.613% |
DRS Leonardo DRS, Inc. | 7,090 | $146,979.61 | $326,494.49 | - | $179,514.88 | 122.14% | +0.943% |
ECL Ecolab Inc. | 957 | $242,618.71 | $265,691.91 | - | $23,073.2 | 9.51% | -0.612% |